LPL Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $335M | Buy |
13,919,821
+526,160
| +4% | +$13.8M | 0.08% | 261 |
|
|
2026
Q1 | $376M | Buy |
13,393,661
+124,181
| +0.9% | +$3.31M | 0.1% | 206 |
|
|
2025
Q4 | $330M | Buy |
13,269,480
+1,131,225
| +9% | +$28.5M | 0.09% | 210 |
|
|
2025
Q3 | $309M | Buy |
12,138,255
+686,732
| +6% | +$16.9M | 0.09% | 206 |
|
|
2025
Q2 | $278M | Buy |
11,451,523
+940,757
| +9% | +$21.9M | 0.09% | 207 |
|
|
2025
Q1 | $266M | Buy |
10,510,766
+533,763
| +5% | +$14M | 0.1% | 186 |
|
|
2024
Q4 | $265M | Sell |
9,977,003
-24,239
| -0.2% | -$657K | 0.11% | 173 |
|
|
2024
Q3 | $289M | Buy |
10,001,242
+777,478
| +8% | +$22.7M | 0.13% | 146 |
|
|
2024
Q2 | $258M | Buy |
9,223,764
+942,218
| +11% | +$25.9M | 0.13% | 145 |
|
|
2024
Q1 | $230M | Buy |
8,281,546
+1,688,773
| +26% | +$46.9M | 0.12% | 155 |
|
|
2023
Q4 | $190M | Sell |
6,592,773
-323,661
| -5% | -$9.78M | 0.12% | 164 |
|
|
2023
Q3 | $229M | Buy |
6,916,434
+349,581
| +5% | +$12.4M | 0.16% | 121 |
|
|
2023
Q2 | $241M | Buy |
6,566,853
+438,067
| +7% | +$17.1M | 0.17% | 119 |
|
|
2023
Q1 | $250M | Buy |
6,128,786
+714,679
| +13% | +$30.9M | 0.19% | 106 |
|
|
2022
Q4 | $277M | Buy |
5,414,107
+345,594
| +7% | +$16.6M | 0.24% | 91 |
|
|
2022
Q3 | $222M | Buy |
5,068,513
+46,763
| +0.9% | +$2.27M | 0.21% | 97 |
|
|
2022
Q2 | $263M | Buy |
5,021,750
+55,368
| +1% | +$2.82M | 0.25% | 85 |
|
|
2022
Q1 | $257M | Buy |
4,966,382
+339,147
| +7% | +$17.6M | 0.22% | 91 |
|
|
2021
Q4 | $273M | Buy |
4,627,235
+192,717
| +4% | +$9.55M | 0.23% | 84 |
|
|
2021
Q3 | $191M | Buy |
4,434,518
+143,722
| +3% | +$6.37M | 0.18% | 113 |
|
|
2021
Q2 | $168M | Buy |
4,290,796
+332,710
| +8% | +$12.9M | 0.17% | 111 |
|
|
2021
Q1 | $143M | Buy |
3,958,086
+58,487
| +1% | +$2.08M | 0.16% | 116 |
|
|
2020
Q4 | $144M | Buy |
3,899,599
+247,191
| +7% | +$9.07M | 0.19% | 107 |
|
|
2020
Q3 | $127M | Buy |
3,652,408
+327,452
| +10% | +$11.5M | 0.2% | 102 |
|
|
2020
Q2 | $103M | Buy |
3,324,956
+316,274
| +11% | +$10.7M | 0.18% | 114 |
|
|
2020
Q1 | $93.2M | Buy |
3,008,682
+184,601
| +7% | +$6.29M | 0.2% | 96 |
|
|
2019
Q4 | $105M | Buy |
2,824,081
+459,220
| +19% | +$16.4M | 0.19% | 100 |
|
|
2019
Q3 | $80.6M | Buy |
2,364,861
+264,543
| +13% | +$9.62M | 0.16% | 119 |
|
|
2019
Q2 | $86.3M | Buy |
2,100,318
+208,747
| +11% | +$8.29M | 0.18% | 106 |
|
|
2019
Q1 | $76.2M | Buy |
1,891,571
+77,082
| +4% | +$3.09M | 0.17% | 112 |
|
|
2018
Q4 | $75.1M | Sell |
1,814,489
-187,036
| -9% | -$7.76M | 0.2% | 100 |
|
|
2018
Q3 | $83.7M | Buy |
2,001,525
+99,733
| +5% | +$3.84M | 0.2% | 99 |
|
|
2018
Q2 | $65.5M | Buy |
1,901,792
+12,416
| +0.7% | +$424K | 0.17% | 110 |
|
|
2018
Q1 | $63.6M | Buy |
1,889,376
+221,767
| +13% | +$7.62M | 0.18% | 108 |
|
|
2017
Q4 | $57.3M | Buy |
1,667,609
+175,648
| +12% | +$5.99M | 0.17% | 111 |
|
|
2017
Q3 | $50.5M | Buy |
1,491,961
+42,165
| +3% | +$1.36M | 0.18% | 106 |
|
|
2017
Q2 | $46.2M | Buy |
1,449,796
+1,191,184
| +461% | +$37.6M | 0.18% | 114 |
|
|
2017
Q1 | $8.4M | Buy |
258,612
+29,644
| +13% | +$935K | 0.06% | 286 |
|
|
2016
Q4 | $7.17M | Buy |
228,968
+11,890
| +5% | +$363K | 0.05% | 303 |
|
|
2016
Q3 | $6.95M | Buy |
217,078
+26,979
| +14% | +$902K | 0.07% | 279 |
|
|
2016
Q2 | $6.47M | Sell |
190,099
-2,086,849
| -92% | -$66.6M | 0.05% | 296 |
|
|
2016
Q1 | $67.7M | Buy |
2,276,948
+152,928
| +7% | +$4.37M | 0.19% | 115 |
|
|
2015
Q4 | $64.8M | Buy |
2,124,020
+935,455
| +79% | +$29.4M | 0.18% | 115 |
|
|
2015
Q3 | $37.8M | Buy |
1,188,565
+29,763
| +3% | +$954K | 0.21% | 104 |
|
|
2015
Q2 | $36.6M | Sell |
1,158,802
-15,107
| -1% | -$492K | 0.19% | 112 |
|
|
2015
Q1 | $38.2M | Buy |
1,173,909
+15,682
| +1% | +$499K | 0.2% | 103 |
|
|
2014
Q4 | $34.2M | Buy |
1,158,227
+53,887
| +5% | +$1.55M | 0.19% | 110 |
|
|
2014
Q3 | $30.5M | Sell |
1,104,340
-87,906
| -7% | -$2.47M | 0.18% | 117 |
|
|
2014
Q2 | $33.6M | Buy |
1,192,246
+39,604
| +3% | +$1.13M | 0.2% | 111 |
|
|
2014
Q1 | $35.1M | Buy |
1,152,642
+4,254
| +0.4% | +$127K | 0.22% | 95 |
|
|
2013
Q4 | $33.4M | Sell |
1,148,388
-11,958
| -1% | -$348K | 0.21% | 98 |
|
|
2013
Q3 | $32.3M | Sell |
1,160,346
-24,671
| -2% | -$671K | 0.22% | 93 |
|
|
2013
Q2 | $31.5M | Buy |
+1,185,017
| New | +$32.7M | 0.23% | 86 |
|
Other funds holding PFE
LPL Financial's PFE Position: Q2 2026 in Review
LPL Financial increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $13.8M and bringing the position to 13,919,821 shares worth $335M. The position accounts for 0.08% of the portfolio, ranked #261.
LPL Financial first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $376M in Q1 2026. 1,776 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LPL Financial held 13,919,821 shares of Pfizer worth $335M as of Q2 2026.
- LPL Financial bought 526,160 Pfizer shares in Q2 2026, an estimated $13.8M.
- Pfizer made up 0.08% of LPL Financial's portfolio in Q2 2026, its #261 holding.
- LPL Financial first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- LPL Financial's Pfizer position peaked at $376M in Q1 2026.
- 1,776 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.